Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for MDGEF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2001. Start Trial.
Date Value
December 31, 2019 12.93M
September 30, 2019 12.93M
June 30, 2019 12.93M
March 31, 2019 12.93M
December 31, 2018 12.93M
September 30, 2018 12.93M
June 30, 2018 12.93M
March 31, 2018 11.75M
December 31, 2017 11.74M
September 30, 2017 11.74M
June 30, 2017 11.65M
March 31, 2017 10.61M
December 31, 2016 10.60M
September 30, 2016 10.60M
June 30, 2016 10.58M
March 31, 2016 10.37M
December 31, 2015 10.36M
September 30, 2015 10.36M
June 30, 2015 7.399M
March 31, 2015 7.348M
December 31, 2014 7.333M
September 30, 2014 7.329M
June 30, 2014 5.734M
March 31, 2014 5.734M
December 31, 2013 5.198M
Date Value
September 30, 2013 5.198M
June 30, 2013 5.198M
March 31, 2013 4.881M
December 31, 2012 4.881M
September 30, 2012 4.881M
June 30, 2012 4.881M
March 31, 2012 4.881M
December 31, 2011 4.881M
September 30, 2011 4.881M
June 30, 2011 4.881M
March 31, 2011 4.881M
September 30, 2010 4.881M
June 30, 2010 4.479M
March 31, 2010 4.756M
December 31, 2009 4.680M
September 30, 2009 4.482M
June 30, 2009 4.482M
March 31, 2009 4.479M
December 31, 2008 4.479M
September 30, 2008 4.479M
June 30, 2008 4.479M
March 31, 2008 4.474M
December 31, 2007 4.468M
September 30, 2007 4.468M
June 30, 2007 4.06M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
InflaRx NV 147.37M
BioNTech SE 251.20M
Immatics NV 136.69M
Arrowhead Pharmaceuticals, Inc. 141.14M
Oncolytics Biotech, Inc. 124.64M